TCI Wealth Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
BC
WA
TCI Wealth Advisors's VKTX Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Viking Therapeutics (VKTX) in Q2 2023, closing a stake of 300 shares — an estimated $5K sold.
TCI Wealth Advisors first reported a position in VKTX in Q1 2018 and held it in 21 quarters. The position peaked at $21K in Q3 2018. 193 funds tracked by Wall St. Rank hold VKTX as of Q2 2023.
- TCI Wealth Advisors reported no remaining Viking Therapeutics position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 300 Viking Therapeutics shares in Q2 2023, an estimated $5K.
- TCI Wealth Advisors first reported a position in Viking Therapeutics in Q1 2018 and held it in 21 quarters.
- TCI Wealth Advisors's Viking Therapeutics position peaked at $21K in Q3 2018.
- 193 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.